The short version of Coordination complex fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-20 and is reviewed periodically as new material appears.
Published work on GHK-Cu is dominated by in vitro experiments and small animal studies. Human trials tend to be short and small, with endpoints such as skin appearance rather than clinical outcomes. Review articles often summarize the same underlying laboratory findings, which can make the evidence base look broader than it is. Several basic questions remain open: the concentration of the intact complex in human tissue, the route by which it crosses the skin barrier, and whether effects seen in culture produce measurable changes in people.
Laboratory studies describe GHK-Cu as a source of copper that cells can take up, with reported effects on collagen, elastin, and glycosaminoglycan synthesis in cultured fibroblasts. The peptide also appears in wound-repair research, where it is linked to the activity of matrix metalloproteinases and their inhibitors. These observations come largely from cell and animal models. How directly the complex controls any single pathway in intact human skin remains an open question, and reported effects depend on concentration, vehicle, and exposure time.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Copper content is measured separately by techniques such as inductively coupled plasma mass spectrometry or atomic absorption. Amino acid analysis confirms the peptide sequence after hydrolysis. Because the metal and the peptide can be quantified independently, a complete certificate of analysis normally reports both values rather than a single purity figure. This separation of measurements is important when comparing suppliers.
Solid GHK-Cu appears as a blue to blue-violet powder, and the colour is a direct consequence of copper coordination. The complex dissolves readily in water and in many polar solvents, while the free peptide behaves differently. Solubility in nonpolar media is low, which limits its use in oil-based systems. Solutions are typically prepared fresh because the dissolved form is more exposed to hydrolysis and to loss of the metal ion than the dry powder. Working concentrations are usually low, and preparation notes often specify the solvent and the order of addition.
Dry material is typically held at low temperature, often around minus twenty degrees Celsius, and protected from moisture and light. Copper complexes can release their metal ion under acidic conditions or in the presence of competing chelators. Hydrolysis of the peptide backbone is a slower but real pathway, and the histidine residue is susceptible to oxidation over long periods. Stability statements therefore depend on formulation, pH, and container, and they should be read as conditional rather than absolute.
| Property | Value | Notes |
|---|---|---|
| Copper binding sites | Imidazole, amino, and amide nitrogens | Form chelate rings with Cu(II) |
| Conditional binding constant | Reported near 10^16 at neutral pH | Value depends on method and medium |
| Visible absorption | Broad band in the blue-violet region | Source of the characteristic color |
| Common analytical methods | LC-MS, HPLC, UV-Vis, ICP-OES | Used for identity and copper content |
| Main degradation routes | Oxidation, photolysis, hydrolysis | Accelerated by light, heat, and pH extremes |
Dry material is normally held cold, commonly at -20 °C for long-term storage and 2 to 8 °C for working quantities, protected from light and moisture. Vials should be allowed to reach room temperature before opening so that condensation does not form on the powder. In liquid formulations the complex is generally kept near neutral to slightly acidic pH, because strongly alkaline conditions favour precipitation of copper hydroxide. Antioxidants or chelate-stabilising excipients are often added, though the specific approaches are proprietary and rarely published in detail.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.
Aqueous solutions of GHK-Cu are less stable than the dry powder. The peptide backbone is vulnerable to hydrolysis at extreme pH, and copper can be stripped from the complex by strong chelating agents such as EDTA or citrate. Oxidising agents and high concentrations of ascorbic acid can reduce copper(II) and change the complex, which is one reason formulators often keep such ingredients in separate phases. How quickly these changes occur under real storage conditions depends on pH, buffer, temperature and packaging, and quantitative data on the subject are limited.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Research interest in GHK-Cu centers on its ability to deliver copper and to influence cellular processes in laboratory models. In cell culture and animal studies, the complex has been linked to collagen synthesis, antioxidant enzyme activity, and expression of genes associated with tissue remodeling. These effects are not equivalent to proven clinical outcomes. The mechanisms proposed include copper transfer to cuproenzymes, modulation of growth factor signaling, and interactions with extracellular matrix components. How much of the observed activity depends on intact GHK-Cu versus free copper or free peptide is not fully resolved.
The compound entered scientific literature in the 1970s, when plasma factors with copper-binding activity were isolated and characterized. Later work expanded into wound healing, skin biology, and cosmetic formulation, where copper tripeptide-1 became a recognized ingredient name. Most published studies remain preclinical or small-scale, and findings are often reported in specialized dermatology or peptide journals. Regulatory treatment varies: some jurisdictions allow it as a cosmetic ingredient, while research-grade material is sold for laboratory use. Questions about optimal delivery, target tissues, and long-term effects continue to be investigated rather than settled.
==== De novo motif discovery ==== There are software programs which, given multiple input sequences, attempt to identify one or more candidate motifs. One example is the Multiple EM for Motif Elicitation (MEME) algorithm, which generates statistical information for each candidate. There are more than 100 publications detailing motif discovery algorithms; Weirauch et al. evaluated many related algorithms in a 2013 benchmark. The planted motif search is another motif discovery method that is based on combinatorial approach.
In autumn 1981 he visited Liverpool again, this time with a thirty-strong task force of representatives of local employers and civil servants (unusually for the time, drawn from different departments – DOE, DTI and Employment, but not the Home Office this time – Heseltine had been pushing for greater cooperation between departments since the setting up of the European Space Agency in 1973). For the next fifteen months he visited Liverpool for a day almost every week, refusing police protection and often driving himself, persuading business and local government to work together. Colette Bowe, a DTI official who was deputy director of the task force, recorded that Heseltine was the most effective minister she had ever seen at getting the official machine to do his bidding through a mixture of charm and tough questions.
Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins that share a conserved catalytic core. The structures of over 280 human protein kinases have been determined. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine amino acid, which has been shown to be involved in ATP binding. In the central part of the catalytic domain, there is a conserved aspartic acid, which is important for the catalytic activity of the enzyme.
I was holding excerpts (photocopies were not so accessible then) from the author's certificate USSR № 1247973 to which I have referred in all my works on the Orbitrap™ analyzer since then." Alexander Makarov's effort in commercializing Orbitrap analyzer at the end of the 1990s required a number of innovations such as image current detection, C-trap for ion injection, and other technology improvements which resulted in the commercial introduction of this analyzer by Thermo Fisher Scientific as a part of the hybrid LTQ Orbitrap instrument in 2005.
Narrated by Paul Barry, produced by Daryl Karp, directed by Richard Smith, an Australian production, made by ABC 25 September Cleared for Take-off, the years leading to the first flight of the Boeing 777, planned for May 1995; testing the Boeing 777 APU in cold weather in Alaska; Boeing put £5bn into the testing; Alan Mulally, head of the 777 team; the evangelical management process of 'Working Together', to avoid secrecy; Ronald Ostrowski, director of engineering on the 777; the engines cost 20% of the total cost; Granville Frazier of propulsion; the ETOPS standard for twin-engined aircraft; Chester Ekstrand; the first ever 747 is fitted with a 777 testbed engine; the Pratt Whitney test rig at the Aero-propulsion Systems Test Facility at Tullahoma, Tennessee; Baldey Mehta of the 777 engine; John Cashman, the chief 777 test pilot; the 777 engine testbed has an engine surge, on take off; Thomas Davenport, head of the 777 program for Pratt Whitney; Rocky Thomas of Propulsion; the 777 fuselage is pressurised in January 1994, for the first time from 5 psi to 12 psi; Philip M. Condit; Neil Standal of the fabrication division; Jim McWha of flight testing; Lyle Eveland, head of factory operations; the 777 has its first flight on 12 June 1994, to test the aircraft stability; Frank Shrontz, head of Boeing.
Sources: en.wikipedia.org
== Legacy == Ajayaghosh's research have been principally in the fields of supramolecular chemistry, chemosensors, low band-gap polymers, fluorescent gels, organic nanostructures, and photoresponsive systems and he is reported to have done extensive researches on supramolecular architecture and light-induced sensor systems. He is known to have pioneered the study of molecular self-assembly in India and is credited with the creation of a new category of self-assembled materials that are functionally soft. His work assisted in the design of larger molecular structures using self-assembling molecules and demonstrated ways to control their electrical conductivity through controlling external factors like temperature which have reported use in applications involving light harvesting, sensing, imaging, and security. He was the first scientist to design functional Phenylenevinylene-based Organogels from designed building blocks, which has been detailed in his article, First Phenylenevinylene Based Organogels: Self-Assembled Nanostructures via Cooperative Hydrogen Bonding and π-Stacking, published in 2001. One of the commercial applications of his research is secret writing, thermally writable, non-copyable, and erasable fluorescent images useful for secret documentation by using a fluorescent gelator entrapped in a polystyrene film and the process has been developed by his team. His studies have been documented in several peer-reviewed articles; ResearchGate and Google Scholar, online repositories of scientific articles, have listed 202 and 162 of them respectively.
== Mechanism of action == Naltrexone and its active metabolite, 6-β-naltrexol, are competitive antagonists at μ-opioid, κ-opioid, and, to a lesser extent, δ-opioid receptors. Standard therapeutic doses of naltrexone block these receptors, achieving two main effects: first, they prevent the inhibition of GABA receptors, which normally suppress neuron activity; many recreational drugs inhibit GABA, thereby increasing neuronal activation, and by blocking GABA inhibition, normal GABA activity resumes. Second, naltrexone blocks dopamine release, since many recreational drugs stimulate dopamine as part of the brain's reward system, which generates feelings of pleasure. As naltrexone is a competitive antagonist at the identical sites of action of many opioid agonists, such as morphine, care must be taken to ensure that low-dose naltrexone is not taken near the same time as these medications, as they will not be as efficacious in relieving pain.
Small-cell carcinoma is an undifferentiated neoplasm composed of primitive-appearing cells. As the name implies, the cells in small-cell carcinomas are smaller than normal cells and barely have room for any cytoplasm. Some researchers identify this as a failure in the mechanism that controls the size of the cells. At the time of diagnosis, 60–70% of people already have metastases.
Zinc dialkyldithiophosphates (often referred to as ZDDP) are a family of coordination compounds classified as members of transition metal dithiophosphate complexes. These compounds were introduced in the 1940s as oil additives. They are uncharged compounds, not salts. They are soluble in nonpolar solvents, and the longer-chain derivatives easily dissolve in mineral and synthetic oils used as lubricants. They come under CAS number 68649-42-3 . In aftermarket oil additives, the percentage of ZDDP ranges approximately between 2 and 15%. Zinc dithiophosphates have many names, including ZDDP, ZnDTP, and ZDP.
Sources: en.wikipedia.org
Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. Both animals kept as pets and animals raised as livestock are routinely vaccinated. In some instances, wild populations may be vaccinated. This is sometimes accomplished with vaccine-laced food spread in a disease-prone area and has been used to attempt to control rabies in raccoons. Where rabies occurs, rabies vaccination of dogs may be required by law. Other canine vaccines include canine distemper, canine parvovirus, infectious canine hepatitis, adenovirus-2, leptospirosis, Bordetella, canine parainfluenza virus, and Lyme disease, among others. Cases of veterinary vaccines used in humans have been documented, whether intentional or accidental, with some cases of resultant illness, most notably with brucellosis. However, the reporting of such cases is rare and very little has been studied about the safety and results of such practices. With the advent of aerosol vaccination in veterinary clinics, human exposure to pathogens not naturally carried in humans, such as Bordetella bronchiseptica, has likely increased in recent years. In some cases, most notably rabies, the parallel veterinary vaccine against a pathogen may be as much as orders of magnitude more economical than the human one.
==== Quest for milk substitutes ==== Poorer consumers reliant on local infant formula, which was approximately half the price of imported brands, had been left without alternatives to feed their children. Many had lost faith in local brands, with others unsure of which brands were safe. Supermarket shelves had been swept bare from product recalls. Shops in Hong Kong reported a rush for imported formula from cross-border shoppers, with some retailers reportedly rationing their stocks. Some mainlanders were also reportedly rushing to import infant formula from Kinmen. Wet nurses enjoyed a resurgence in popularity in major cities. Some media reports have documented that Chinese sailors and expatriates have been buying local dairy produce in Australia to send back to relatives in China. It had been estimated in 2018 that up to 80% to 90% of infant formula purchased in Australia was destined for China. Following widespread complaints and appeals by exasperated Australian parents unable to find formula for their children, Coles supermarkets resorted to locking baby formula tins away behind the Service Counter, like tobacco products, in order to regulate their sale. The two major supermarkets, Coles and Woolworths, placed a two item limit on baby formula purchases to curb the growing practice of bulk purchasing by predominantly Chinese customers known as daigou, or "personal shoppers".
==== 2024: Ninth year of eligibility ==== When moving from Oregon to Miami, McCormick left the Pac-12 Conference and joined the Atlantic Coast Conference. As a result, McCormick was required to submit a petition to his new conference to receive a ninth year of eligibility. He did so and was granted a ninth year of eligibility. He is thought to be the first football player to have been granted such eligibility, and he has announced plans to return to the University of Miami for another year to play football during the 2024 Miami Hurricanes football season.
From the DNVP no attempt of relieving the situation is to be expected." According to English historian Richard J. Evans, the main reason why the Centre Party voted for the Enabling Act despite questioning the sincerity of Hitler's guarantees was because of the intimidation that it was subjected to. The party was further pressured by the fact that on 26 June 1933, all of the Reichstag and Landtag deputies of the Bavarian People's Party were placed in custody by Heinrich Himmler. This was also followed by the Nazi troops forcefully disbanding the Catholic trade unions, and Catholic civil servants being threatened with dismissals. In light of the increasing oppression, most members of the Centre Party believed that they were powerless to prevent the NSDAP from gaining power. Evan wrote:
==== Breast cancer ==== The feasibility of 68Ga-Trivehexin PET imaging of breast cancer (BC) was demonstrated in a case of triple-negative BC. Another report suggested that 68Ga-Trivehexin PET/CT might offer superior detection efficacy for breast cancer compared to 18F-FDG PET/CT. Furthermore, in progesterone- and estrogen-receptor negative BC with elevated Ki67 proliferation index and strong E-cadherin, 68Ga-Trivehexin PET identified several 18F-FDG-avid lymph nodes as false positives. In a patient with lobular BC and pancreatic neuroendocrine tumor (PNET), 68Ga-Trivehexin selectively showed a PET signal only in the lobular carcinoma, while the metabolic tracer 18F-FGD and the neuroendocrine tumor tracer 68Ga-DOTATATE yielded PET signals for both the BC and PNET lesions.
Sources: en.wikipedia.org
It is not approved as a pharmaceutical in major markets and is used mainly as a cosmetic ingredient and a laboratory reagent. Regulatory status varies by country and by the product category in which it appears. Claims about therapeutic effects should be treated separately from permitted cosmetic labeling.
Reversed-phase high-performance liquid chromatography and mass spectrometry are common for the peptide portion. Copper content is usually determined by inductively coupled plasma techniques or by spectrophotometry. Ultraviolet-visible spectroscopy takes advantage of the visible absorption band of the copper complex.
Light, oxygen, and elevated temperature promote degradation of the peptide, and strongly acidic or alkaline conditions accelerate hydrolysis. The copper complex is generally more resistant to oxidation than the free peptide. Storage in a dry, dark, cold environment limits loss over time.
The colour comes from electronic transitions in the coordinated copper(II) ion. Ligand field effects absorb part of the visible spectrum. A colourless or greenish sample may indicate degraded material.